Migraine Clinical Trials
Migraine clinical trials test new and emerging treatments to see how well they prevent or relieve migraine attacks and how safe they are for patients. They offer eligible participants access to cutting‑edge therapies, careful medical monitoring, and a chance to contribute to research that may improve migraine care for others in the future.
THRIVE
Infusion
The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).
MERZ MINT-C
Injections
In this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine days with Xeomin injections compared to Placebo injections.
MERZ MINT-E
Injections
In this clinical trial, participants with episodic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine days with Xeomin injections compared to Placebo injections.